AMRS News and Press, Amyris Inc. From 01/30/23

AMYRIS LAUNCHES 4U BY TIA™ HAIRCARE LINE EXCLUSIVELY AT WALMART PR Newswire EMERYVILLE, Calif. , Jan. 30, 2023 /PRNewswire/ -- Amyris , Inc. ( Nasdaq : AMRS ), a leading synthetic biotechnology company accelerating the world's transition to susta...

Short Interest Stocks To Watch This Week Were you introduced to the stock market in 2020 and 2021 when meme stocks surged? At the time, some of the most well-known penny stocks , including AMC Entertainment and GameStop, surged to record levels. The “Fight Against The Hedgiesȁ...

Summary Uncertainty still surrounds the strategic transaction, but it is still likely to close in the coming weeks. Amyris' cash flow problems are improving rapidly, but a large amount of outside cash will likely still be needed to reach profitability. Barring bankruptcy, Amyris' st...

AMYRIS TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTH CARE CONFERENCE PR Newswire EMERYVILLE, Calif. , Jan. 4, 2023 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable co...

Synthetic biotechnology company Amyris, Inc. ( NASDAQ: AMRS ) announced Thursday a registered direct offering of common stock and a private placement to raise ~$50M in gross proceeds. The registered direct offering allows the purchase and sale of 20M shares of the company's common sto...

AMYRIS ANNOUNCES $50 MILLION REGISTERED DIRECT OFFERING AND CONCURRENT PRIVATE PLACEMENT PR Newswire EMERYVILLE, Calif. , Dec. 29, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to s...

Summary Amyris announces delay to key strategic transaction allegedly due to antitrust review requirements. A definitive agreement doesn't appear to have been reached yet. Two weeks ago, Amyris surprisingly fired its long-standing Chief Legal Officer, a highly unusual move in the midst ...

Amyris ( NASDAQ: AMRS ) has completed the negotiation of an agreement worth $500M to license the distribution and marketing of two of the company's ingredients. Shares are up ~7% in pre-market trading. The deal is expected to close in Q1 2023. The other party in the tr...

AMYRIS SUCCESSFULLY ADVANCES STRATEGIC TRANSACTION PR Newswire EMERYVILLE, Calif. , Dec. 27, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Mark...

Hot Penny Stocks To Buy For Under $3 Are you looking for penny stocks to buy today? You’re not alone, and the process of finding them isn’t as easy as you might think. One of the main reasons is the much higher volatility in the stock market today. It isn’t just penny s...